Repligen Corp.
RGEN
Market Cap$6.88B
Close$
$65.02
46.1% downside
Current Fair Value
46.1% downsideOvervalued by 46.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.88 Billion |
|---|---|
| Enterprise Value | $6.71 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.46 |
| Beta | 1.05 |
| Outstanding Shares | 56,178,879 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -496.98 |
|---|---|
| PEG | -142.96 |
| Price to Sales | 10.96 |
| Price to Book Ratio | 3.45 |
| Enterprise Value to Revenue | 9.96 |
| Enterprise Value to EBIT | 356.42 |
| Enterprise Value to Net Income | 1343 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.27 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Repligen Corp.
CEO: Anthony Hunt